La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Shrenik Crescita futura

Future criteri di controllo 0/6

Al momento non disponiamo di una copertura analitica sufficiente per prevedere la crescita e il fatturato di Shrenik.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Trade Distributors crescita degli utili	8.8%
Tasso di crescita dei ricavi	n/a
Rendimento futuro del capitale proprio	n/a
Copertura analitica	None
Ultimo aggiornamento	n/a

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

Should You Be Worried About Shrenik Limited's (NSE:SHRENIK) 1.5% Return On Equity?

Mar 07

Here's Why Shrenik (NSE:SHRENIK) Is Weighed Down By Its Debt Load

Feb 15

Estimating The Intrinsic Value Of Shrenik Limited (NSE:SHRENIK)

Jan 28

Is Shrenik (NSE:SHRENIK) Likely To Turn Things Around?

Jan 11

Should Shrenik Limited (NSE:SHRENIK) Be Part Of Your Dividend Portfolio?

Dec 14

In questa sezione di solito presentiamo le proiezioni di crescita dei ricavi e degli utili basate sulle stime di consenso degli analisti professionisti per aiutare gli investitori a capire la capacità della società di generare profitti. Tuttavia, poiché Shrenik non ha fornito dati sufficienti sul passato e non ha previsioni degli analisti, i suoi utili futuri non possono essere calcolati in modo affidabile estrapolando i dati passati o utilizzando le previsioni degli analisti.

Si tratta di una situazione piuttosto rara, dato che il 97% delle società coperte da SimplyWall St dispone di dati finanziari passati.

Previsioni di crescita degli utili e dei ricavi

NSEI:SHRENIK - Stime future degli analisti e dati finanziari passati (INR Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
6/30/2024	288	-616	N/A	N/A	N/A
3/31/2024	342	-1,089	-19	1,252	N/A
12/31/2023	402	-34	N/A	N/A	N/A
6/30/2023	452	-481	N/A	N/A	N/A
3/31/2023	486	2	468	469	N/A
12/31/2022	482	-11	N/A	N/A	N/A
9/30/2022	461	-28	-94	-94	N/A
6/30/2022	417	-101	N/A	N/A	N/A
3/31/2022	638	-144	-77	-77	N/A
12/31/2021	1,356	-116	N/A	N/A	N/A
9/30/2021	1,721	-117	98	98	N/A
6/30/2021	3,390	-31	N/A	N/A	N/A
3/31/2021	3,637	-15	269	269	N/A
12/31/2020	4,198	11	N/A	N/A	N/A
9/30/2020	5,759	53	231	235	N/A
6/30/2020	6,250	61	N/A	N/A	N/A
3/31/2020	7,956	113	85	104	N/A
12/31/2019	8,771	140	N/A	N/A	N/A
9/30/2019	8,956	134	-369	-301	N/A
6/30/2019	8,683	120	N/A	N/A	N/A
3/31/2019	8,368	111	-247	-181	N/A
12/31/2018	7,743	94	N/A	N/A	N/A
9/30/2018	7,131	93	N/A	N/A	N/A
6/30/2018	6,532	86	N/A	N/A	N/A
3/31/2018	5,932	79	N/A	-469	N/A
3/31/2017	4,277	42	N/A	-131	N/A
3/31/2016	3,292	29	N/A	-75	N/A
3/31/2015	2,657	10	N/A	60	N/A
3/31/2014	2,131	10	N/A	-73	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Dati insufficienti per determinare se la crescita degli utili prevista SHRENIK è superiore al tasso di risparmio ( 6.7% ).

Guadagni vs Mercato: Dati insufficienti per determinare se si prevede che gli utili di SHRENIK cresceranno più velocemente del mercato Indian

Guadagni ad alta crescita: Dati insufficienti per determinare se si prevede che gli utili di SHRENIK cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Dati insufficienti per determinare se si prevede che i ricavi di SHRENIK cresceranno più rapidamente del mercato Indian.

Ricavi ad alta crescita: Dati insufficienti per determinare se si prevede che i ricavi di SHRENIK cresceranno più rapidamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di SHRENIK è previsto essere elevato tra 3 anni

Shrenik Crescita futura

Future criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Recent updates

First quarter 2025 earnings released

Chairman & MD recently sold ₹181k worth of stock

Chairman & MD recently sold ₹728k worth of stock

Insufficient new directors

Shrenik Limited Appoints Nirav Harshvadan Zaveri as Independent Director

Full year 2024 earnings released

Chairman & MD recently sold ₹6.5m worth of stock

Chairman & MD recently sold ₹295k worth of stock

Chairman & MD recently sold ₹1.1m worth of stock

Chairman & MD recently sold ₹542k worth of stock

Chairman & MD recently sold ₹207k worth of stock

Chairman & MD recently sold ₹543k worth of stock

Chairman & MD recently sold ₹544k worth of stock

Third quarter 2024 earnings released

Chairman & MD recently sold ₹626k worth of stock

Chairman & MD recently sold ₹370k worth of stock

Chairman & MD recently sold ₹1.0m worth of stock

Chairman & MD recently sold ₹1.7m worth of stock

Chairman & MD recently sold ₹973k worth of stock

Is Shrenik (NSE:SHRENIK) A Risky Investment?

Chairman & MD recently sold ₹935k worth of stock

First quarter 2024 earnings released: ₹0.77 loss per share (vs ₹0.01 profit in 1Q 2023)

Chairman & MD recently sold ₹1.3m worth of stock

Chairman & MD recently sold ₹1.2m worth of stock

Full year 2023 earnings released: EPS: ₹0.004 (vs ₹0.23 loss in FY 2022)

Chairman & MD recently sold ₹1.1m worth of stock

Is Shrenik (NSE:SHRENIK) Using Debt Sensibly?

Chairman & MD recently sold ₹108k worth of stock

Chairman & MD recently sold ₹2.4m worth of stock

Chairman & MD recently sold ₹2.5m worth of stock

Chairman & MD recently sold ₹1.6m worth of stock

Third quarter 2023 earnings released: EPS: ₹0.01 (vs ₹0.02 loss in 3Q 2022)

Is Shrenik (NSE:SHRENIK) A Risky Investment?

Chairman & MD recently sold ₹425k worth of stock

Chairman & MD recently sold ₹481k worth of stock

Chairman & MD recently sold ₹140k worth of stock

Chairman & MD recently sold ₹805k worth of stock

Second quarter 2023 earnings released: EPS: ₹0.03 (vs ₹0.09 loss in 2Q 2022)

Chairman & MD recently sold ₹519k worth of stock

Is Shrenik (NSE:SHRENIK) A Risky Investment?

Shrenik Limited, Annual General Meeting, Sep 29, 2022

Chairman & MD recently sold ₹774k worth of stock

Chairman & MD recently sold ₹957k worth of stock

Chairman & MD recently sold ₹1.2m worth of stock

First quarter 2023 earnings released: EPS: ₹0.01 (vs ₹0.06 loss in 1Q 2022)

Chairman & MD recently sold ₹190k worth of stock

Chairman & MD recently sold ₹335k worth of stock

Chairman & MD recently sold ₹233k worth of stock

Be Wary Of Shrenik (NSE:SHRENIK) And Its Returns On Capital

Full year 2022 earnings released: ₹0.23 loss per share (vs ₹0.024 loss in FY 2021)

Investors Could Be Concerned With Shrenik's (NSE:SHRENIK) Returns On Capital

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Chairman & MD recently sold ₹12m worth of stock

Shrenik (NSE:SHRENIK) Use Of Debt Could Be Considered Risky

Whole Time Director recently sold ₹9.9m worth of stock

Investors Could Be Concerned With Shrenik's (NSE:SHRENIK) Returns On Capital

Second quarter 2022 earnings released

Chairman & MD recently sold ₹3.6m worth of stock

Insider recently sold ₹782k worth of stock

Board Member recently sold ₹8.5m worth of stock

Does Shrenik (NSE:SHRENIK) Have A Healthy Balance Sheet?

First quarter 2022 earnings released: ₹0.06 loss per share (vs ₹0.03 loss in 1Q 2021)

Independent Director Manali Shah has left the company

Insider recently sold ₹744k worth of stock

Insider recently sold ₹142k worth of stock

Full year 2021 earnings released: ₹0.02 loss per share (vs ₹0.19 profit in FY 2020)

Shrenik's (NSE:SHRENIK) Returns On Capital Not Reflecting Well On The Business

Investor sentiment improved over the past week

Insider recently sold ₹1.1m worth of stock

What Makes Shrenik Limited (NSE:SHRENIK) A Great Dividend Stock?

Insider recently sold ₹332k worth of stock

Investor sentiment deteriorated over the past week

Should You Be Worried About Shrenik Limited's (NSE:SHRENIK) 1.5% Return On Equity?

Insider recently sold ₹7.1m worth of stock

Insider recently sold ₹628k worth of stock